Lack of Longitudinal Association between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD EYE Study. (scientific article published on 21 December 2017)

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Q27860882

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Q29617736

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

Q30837772

A severity scale for diabetic macular edema developed from ETDRS data

Q31158479

Diabetic macular edema associated with glitazone use.

Q33246585

Effects of medical therapies on retinopathy progression in type 2 diabetes

Q33620031

Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy

Q34442253

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

Q34740245

The use of optical coherence tomography to determine the effect of thiazolidinediones on retinal thickness in patients with type 2 diabetes

Q35337098

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Q36864166

Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand.

Q37238060

Perspectives on Some Controversies in Cardiovascular Disease Risk Assessment in the Pharmaceutical Development of Glucose-Lowering Medications

Q39578110

Glitazone use associated with diabetic macular edema

Q46139716

Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database

Q46643138

Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus

Q46699265

Impact of thiazolidinediones on macular thickness and volume in diabetic eyes.

Q47818910

Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).

Q53473497

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

Q58040103

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

Q69874090

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

Q70215925

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema

Q72432533

Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes

Q84356027

P407

language of work or name

English

Q1860

P921

main subject

eye disease

Q3041498

P304

page(s)

138-147

P577

publication date

2017-12-21

P1433

published in

American Journal of Ophthalmology

Q4744258

P1476

title

Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study

P478

volume

187

Reverse relations

cites work (P2860)

Q59797366	Diabetic macular edema: Evidence-based management
Q92406505	Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
Q59624366	Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults